Upgrade to SI Premium - Free Trial

HYDTF (HYDTF)

2.25 -0.07 (3.02%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Insu Therapeutics receives U.S. patent allowance for buccal insulin delivery October 8, 2026 7:30 AM - StreetInsider Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology October 8, 2026 7:30 AM - PR NewsWire Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A August 27, 2026 7:30 AM - PR NewsWire Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston August 6, 2026 7:15 AM - PR NewsWire Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations July 29, 2026 7:00 AM - PR NewsWire Full Article List